<DOC>
	<DOC>NCT02550717</DOC>
	<brief_summary>To investigate the risk of major bleeding (including gastrointestinal and intracranial bleeding episodes) among new users of low-dose acetylsalicylic acid (ASA) in clinical practice</brief_summary>
	<brief_title>Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)</brief_title>
	<detailed_description>These will be based on population-based cohorts using data from a primary care database in the UK: The Health Improvement Network (THIN) and will serve to make a clinically meaningful benefit-risk assessment regarding major bleeding consequences of ASA exposure in general population.</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<criteria>Aged 4084 years Enrolled with the Primary Care Physician (PCP) for at least 2 years, To have a history of computerized prescriptions for at least 1 year prior To have at least one encounter/visit recorded in the last three years To be exposed to low dose ASA before entering in the study Having a diagnosis of cancer before entering in the study Having a diagnosis of alcohol abuse before entering in the study Having a diagnosis of coagulopathies before entering in the study Having a diagnosis of esophageal varices before entering in the study Having a diagnosis of chronic liver disease before entering in the study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Low-dose Acetylsalicylic Acid,</keyword>
	<keyword>Bleeding,</keyword>
	<keyword>The Health Improvement Network (THIN),</keyword>
	<keyword>Cardiovascular</keyword>
	<keyword>Secondary prevention of cardiovascular events</keyword>
</DOC>